Nanomedicine News

RSS

Sorrento and IGDRASOL to Present Nanomedicine Platform Updates at 4th International Nanomedicine Conference

Sorrento Therapeutics, Inc. (Sorrento) and IGDRASOL announced today that the companies will present Phase III interim data analysis of Cynviloq in metastatic breast cancer (MBC) patients showing significantly improved overall response rate (ORR) compared to generic paclitaxel as well as updates of their nanomedicine platform, which is being developed for multiple cancer indications in late-stage clinical trials, at the 4th International Nanomedicine Conference in Sydney Australia (July 1st - 3rd, 2013).

2 Jul 2013

Positive Results from Tekmira's Lipid Nanoparticle Technology-Enabled ALN-TTR02 Phase II Trial for ATTR

Tekmira Pharmaceuticals Corporation, a leading developer of RNA interference (RNAi) therapeutics, today reported that Alnylam Pharmaceuticals, Inc. presented positive results from its Phase II clinical trial with ALN-TTR02, an RNAi therapeutic targeting transthyretin (TTR) for the treatment of TTR-mediated amyloidosis (ATTR), which is enabled by Tekmira's lipid nanoparticle (LNP) technology.

2 Jul 2013

Nanofiber Solutions and Nationwide Children’s Hospital’s Pediatric Surgeon Honored with Ohio Third Frontier Award

Nanofiber Solutions, LLC, in collaboration with Gail E. Besner, MD, chief of Pediatric Surgery, program director of the Residency in Pediatric Surgery and co-director of the Burn Program all at Nationwide Children’s Hospital, recently was honored with the Ohio Third Frontier Technology Validation and Start-up Fund award.

2 Jul 2013

Bioadhesive Coating Increases Intestinal Uptake of Polymer Nanoparticles

In a new study, a “bioadhesive” coating developed at Brown University significantly improved the intestinal absorption into the bloodstream of nanoparticles that someday could carry protein drugs such as insulin. Such a step is necessary for drugs taken by mouth, rather than injected directly into the blood.

28 Jun 2013

Plandai to Encapsulate Phytofare Catechin Complex into Nano-Delivery System for Malaria Treatment

Goldman Small Cap Research, a stock market research firm focused on the small cap and microcap sectors, notes that in a recently released independent study, Plandai Biotechnology Inc.'s flagship product demonstrated a twelve-times greater efficacy in killing the malaria parasite.

27 Jun 2013

NANOBIOTIX Selects Second Product for Development, NBTX-IV

NANOBIOTIX, a clinical-stage nanomedicine company pioneering novel approaches for the local treatment of cancer, announces the selection of a new product for development, NBTX-IV. It is the second product of the NanoXray pipeline which is designed for systemic administration (intravenous injection).

From Nanobiotix 26 Jun 2013

Gold Nanorods Successfully Deliver RSV F Proteins to Immune Cells

Scientists in the US have developed a novel vaccination method that uses tiny gold particles to mimic a virus and carry specific proteins to the body’s specialist immune cells.

26 Jun 2013

Fourth International Nanomedicine Conference Being Hosted by UNSW CAN

The Australian Centre for Nanomedicine (ACN) at UNSW is hosting the fourth International Nanomedicine Conference from 1 – 3 July in Sydney.

25 Jun 2013

New Ways to Maximize Delivery of RNA Strands Carried by Nanoparticles

Nanoparticles that deliver short strands of RNA offer a way to treat cancer and other diseases by shutting off malfunctioning genes. Although this approach has shown some promise, scientists are still not sure exactly what happens to the nanoparticles once they get inside their target cells.

From Massachusetts Institute of Technology 25 Jun 2013

Nanoprobes Detect Specific Genetic Materials from Human Samples

Duke University biomedical engineers and genome researchers have developed a proof-of-principle approach using light to detect infections before patients show symptoms.

24 Jun 2013